NO761526L - - Google Patents
Info
- Publication number
- NO761526L NO761526L NO761526A NO761526A NO761526L NO 761526 L NO761526 L NO 761526L NO 761526 A NO761526 A NO 761526A NO 761526 A NO761526 A NO 761526A NO 761526 L NO761526 L NO 761526L
- Authority
- NO
- Norway
- Prior art keywords
- benzyl
- benzoyl peroxide
- dimethylacetamide
- dimethylformamide
- solution
- Prior art date
Links
- 239000000243 solution Substances 0.000 claims description 17
- 239000004342 Benzoyl peroxide Substances 0.000 claims description 16
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 claims description 16
- 235000019400 benzoyl peroxide Nutrition 0.000 claims description 16
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 15
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 13
- 239000013543 active substance Substances 0.000 claims description 12
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 11
- 238000002347 injection Methods 0.000 claims description 9
- 239000007924 injection Substances 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 229920001800 Shellac Polymers 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 claims description 5
- 239000004208 shellac Substances 0.000 claims description 5
- 229940113147 shellac Drugs 0.000 claims description 5
- 235000013874 shellac Nutrition 0.000 claims description 5
- 241000700605 Viruses Species 0.000 claims description 4
- 241000204031 Mycoplasma Species 0.000 claims description 3
- 201000010099 disease Diseases 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 3
- 210000004051 gastric juice Anatomy 0.000 claims description 3
- 210000000936 intestine Anatomy 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- 206010028980 Neoplasm Diseases 0.000 claims description 2
- 230000001590 oxidative effect Effects 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- -1 -halogen atoms Chemical class 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- WURBFLDFSFBTLW-UHFFFAOYSA-N benzil Chemical compound C=1C=CC=CC=1C(=O)C(=O)C1=CC=CC=C1 WURBFLDFSFBTLW-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1878075 | 1975-05-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO761526L true NO761526L (da) | 1976-11-08 |
Family
ID=10118298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO761526A NO761526L (da) | 1975-05-05 | 1976-05-04 |
Country Status (4)
| Country | Link |
|---|---|
| DK (1) | DK197376A (da) |
| FI (1) | FI761240A7 (da) |
| NO (1) | NO761526L (da) |
| SE (1) | SE7605091L (da) |
-
1976
- 1976-05-03 DK DK197376A patent/DK197376A/da unknown
- 1976-05-04 NO NO761526A patent/NO761526L/no unknown
- 1976-05-04 SE SE7605091A patent/SE7605091L/xx not_active Application Discontinuation
- 1976-05-04 FI FI761240A patent/FI761240A7/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK197376A (da) | 1976-11-06 |
| FI761240A7 (da) | 1976-11-06 |
| SE7605091L (sv) | 1976-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR960005705B1 (ko) | 플로르페니콜의 약제학적 조성물 | |
| Ho et al. | Pyridine nucleotide depletion in pancreatic islets associated with streptozotocin-induced diabetes | |
| US4323577A (en) | Aqueous solution of nitroglycerin | |
| IL45912A (en) | Method and compositions containing glycine glucose electrolytes and mineral salts for treating scours | |
| FR2464717A1 (fr) | Compositions d'agents anti-microbiens a liberation maitrisee et leur utilisation | |
| NO124275B (da) | ||
| NO314831B1 (no) | Farmasöytisk formulering, samt fremgangsmåte for fremstilling og anvendelsederav | |
| KR20090090387A (ko) | 음료수 시스템 내에 추가하기 위한 플로르페니콜의 비등성 제형 | |
| NO761526L (da) | ||
| US3276956A (en) | Treating infections in poultry caused by pleuropneumoniia-like organisms with erythromycin phosphate | |
| US2386157A (en) | Method for the treatment of | |
| FR2531860A1 (fr) | Perfectionnements a des compositions d'alcaloides de vinca | |
| CN113331185B (zh) | 一种自发烟型烟熏消毒剂及其使用方法 | |
| US4500516A (en) | Antibacterial pharmaceutical composition | |
| CN108158981A (zh) | 一种利奈唑胺注射液 | |
| US2799617A (en) | Piperazine adipate compositions and treatment of helminth infections therewith | |
| CN101347406A (zh) | 一种高含量吡喹酮注射液及其制备方法 | |
| KAKEMI et al. | Absorption and Excretion of Drugs. XLI. Studies on the Gastrointestinal Absorption of 2-Pyridine Aldoxime Methiodide and Its Derivatives. | |
| KOMIYA et al. | TECHNIQUES APPLIED IN JAPAN FOR THE CONTROL OF ASCARIS AND HOOKWORM INFECTIONS—A REVIEW— | |
| Rucker et al. | Lignasan for bacterial gill disease | |
| US3136641A (en) | Method of treating eggs | |
| SU1706627A1 (ru) | "Средство дл стерилизации и кастрации самцов млекопитающих разного возраста "Канафен Б" | |
| Bahl | Studies on the Structure, Development, and Physiology of the Nephridia of Oligochaeta PART VIII: Biochemical Estimations of Nutritive and Excretory Substances in the Blood and Coelomic Fluid of the Earthworm and their Bearing on the Role of the Two Fluids in Metabolism | |
| Lin et al. | Disinfection of anesthesia and respiratory therapy equipment with acid glutaraldehyde solution. | |
| CN113350271B (zh) | 一种质子泵抑制剂的组合物及其制备方法 |